(WMS) Advanced Drainage Systems - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US00790R1041
Stock: Pipes, Chambers, Tanks, Filters, Fabrics
Total Rating 49
Risk 80
Buy Signal -1.08
| Risk 5d forecast | |
|---|---|
| Volatility | 38.0% |
| Relative Tail Risk | -11.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.83 |
| Alpha | -2.25 |
| Character TTM | |
|---|---|
| Beta | 1.579 |
| Beta Downside | 1.588 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.75% |
| CAGR/Max DD | 0.51 |
EPS (Earnings per Share)
Revenue
Description: WMS Advanced Drainage Systems March 04, 2026
Advanced Drainage Systems, Inc. (WMS) designs, manufactures, and markets thermoplastic corrugated pipes and water management products. The companys business model focuses on providing solutions for water management across various applications including non-residential, residential, agricultural, and infrastructure projects.
WMS operates through segments including Pipe, Infiltrator, International, and Allied Products & Other. Its product offerings include corrugated polypropylene and polyethylene pipes, plastic leachfield chambers, wastewater purification systems, and septic tanks. The company also distributes construction fabrics and geosynthetic products, which are crucial for soil stabilization and erosion control in the construction sector.
The companys product portfolio also encompasses storm retention/detention solutions, PVC drainage structures, and water quality filters. The water management sector is critical for sustainable development and infrastructure resilience. Further research into WMSs financial performance and market position can provide a deeper understanding of its investment potential. WMS distributes its products through a network of distribution centers.
Headlines to watch out for
- Infrastructure spending drives pipe and water management product demand
- Residential and commercial construction activity impacts sales volume
- Raw material price fluctuations affect production costs
- Regulatory changes for water management influence product demand
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 470.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 4.37 > 1.0 |
| NWC/Revenue: 43.21% < 20% (prev 29.13%; Δ 14.08% < -1%) |
| CFO/TA 0.20 > 3% & CFO 820.4m > Net Income 470.7m |
| Net Debt (437.5m) to EBITDA (895.1m): 0.49 < 3 |
| Current Ratio: 4.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.3m) vs 12m ago 0.28% < -2% |
| Gross Margin: 38.22% > 18% (prev 0.38%; Δ 3.78k% > 0.5%) |
| Asset Turnover: 77.18% > 50% (prev 81.68%; Δ -4.50% > 0%) |
| Interest Coverage Ratio: 7.75 > 6 (EBITDA TTM 895.1m / Interest Expense TTM 91.5m) |
Altman Z'' 5.63
| A: 0.31 (Total Current Assets 1.71b - Total Current Liabilities 413.4m) / Total Assets 4.14b |
| B: 0.44 (Retained Earnings 1.84b / Total Assets 4.14b) |
| C: 0.18 (EBIT TTM 709.1m / Avg Total Assets 3.87b) |
| D: 0.86 (Book Value of Equity 1.83b / Total Liabilities 2.12b) |
| Altman-Z'' Score: 5.63 = AAA |
Beneish M -3.25
| DSRI: 0.94 (Receivables 237.6m/247.9m, Revenue 2.99b/2.94b) |
| GMI: 1.00 (GM 38.22% / 38.06%) |
| AQI: 0.83 (AQ_t 0.31 / AQ_t-1 0.37) |
| SGI: 1.02 (Revenue 2.99b / 2.94b) |
| TATA: -0.08 (NI 470.7m - CFO 820.4m) / TA 4.14b) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
What is the price of WMS shares?
As of March 14, 2026, the stock is trading at USD 147.24 with a total of 711,906 shares traded.
Over the past week, the price has changed by -6.05%, over one month by -19.63%, over three months by -7.36% and over the past year by +31.04%.
Over the past week, the price has changed by -6.05%, over one month by -19.63%, over three months by -7.36% and over the past year by +31.04%.
Is WMS a buy, sell or hold?
Advanced Drainage Systems has received a consensus analysts rating of 4.67.
Therefore, it is recommended to buy WMS.
- StrongBuy: 7
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 197.2 | 33.9% |
| Analysts Target Price | 197.2 | 33.9% |
WMS Fundamental Data Overview March 10, 2026
P/E Trailing = 24.3111
P/E Forward = 21.1864
P/S = 3.8073
P/B = 5.672
P/EG = 1.2456
Revenue TTM = 2.99b USD
EBIT TTM = 709.1m USD
EBITDA TTM = 895.1m USD
Long Term Debt = 1.28b USD (from longTermDebt, last quarter)
Short Term Debt = 43.1m USD (from shortTermDebt, last quarter)
Debt = 1.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 437.5m USD (from netDebt column, last quarter)
Enterprise Value = 11.82b USD (11.38b + Debt 1.45b - CCE 1.01b)
Interest Coverage Ratio = 7.75 (Ebit TTM 709.1m / Interest Expense TTM 91.5m)
EV/FCF = 20.48x (Enterprise Value 11.82b / FCF TTM 577.1m)
FCF Yield = 4.88% (FCF TTM 577.1m / Enterprise Value 11.82b)
FCF Margin = 19.30% (FCF TTM 577.1m / Revenue TTM 2.99b)
Net Margin = 15.75% (Net Income TTM 470.7m / Revenue TTM 2.99b)
Gross Margin = 38.22% ((Revenue TTM 2.99b - Cost of Revenue TTM 1.85b) / Revenue TTM)
Gross Margin QoQ = 35.43% (prev 40.00%)
Tobins Q-Ratio = 2.85 (Enterprise Value 11.82b / Total Assets 4.14b)
Interest Expense / Debt = 1.56% (Interest Expense 22.6m / Debt 1.45b)
Taxrate = 24.53% (30.6m / 124.6m)
NOPAT = 535.2m (EBIT 709.1m * (1 - 24.53%))
Current Ratio = 4.12 (Total Current Assets 1.71b / Total Current Liabilities 413.4m)
Debt / Equity = 0.72 (Debt 1.45b / totalStockholderEquity, last quarter 2.01b)
Debt / EBITDA = 0.49 (Net Debt 437.5m / EBITDA 895.1m)
Debt / FCF = 0.76 (Net Debt 437.5m / FCF TTM 577.1m)
Total Stockholder Equity = 1.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.15% (Net Income 470.7m / Total Assets 4.14b)
RoE = 25.82% (Net Income TTM 470.7m / Total Stockholder Equity 1.82b)
RoCE = 22.88% (EBIT 709.1m / Capital Employed (Equity 1.82b + L.T.Debt 1.28b))
RoIC = 17.33% (NOPAT 535.2m / Invested Capital 3.09b)
WACC = 10.54% (E(11.38b)/V(12.83b) * Re(11.73%) + D(1.45b)/V(12.83b) * Rd(1.56%) * (1-Tc(0.25)))
Discount Rate = 11.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.16%
[DCF] Terminal Value 69.65% ; FCFF base≈483.9m ; Y1≈491.3m ; Y5≈536.3m
[DCF] Fair Price = 75.04 (EV 6.28b - Net Debt 437.5m = Equity 5.85b / Shares 77.9m; r=10.54% [WACC]; 5y FCF grow 1.26% → 2.90% )
EPS Correlation: 21.82 | EPS CAGR: 25.62% | SUE: 0.76 | # QB: 0
Revenue Correlation: -4.82 | Revenue CAGR: 0.59% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.13 | Chg7d=-0.018 | Chg30d=+0.130 | Revisions Net=+4 | Analysts=6
EPS next Year (2027-03-31): EPS=6.86 | Chg7d=-0.025 | Chg30d=+0.415 | Revisions Net=+7 | Growth EPS=+12.0% | Growth Revenue=+13.0%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.6% (Discount Rate 11.7% - Earnings Yield 4.1%)
[Growth] Growth Spread = +5.2% (Analyst 12.8% - Implied 7.6%)
P/E Forward = 21.1864
P/S = 3.8073
P/B = 5.672
P/EG = 1.2456
Revenue TTM = 2.99b USD
EBIT TTM = 709.1m USD
EBITDA TTM = 895.1m USD
Long Term Debt = 1.28b USD (from longTermDebt, last quarter)
Short Term Debt = 43.1m USD (from shortTermDebt, last quarter)
Debt = 1.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 437.5m USD (from netDebt column, last quarter)
Enterprise Value = 11.82b USD (11.38b + Debt 1.45b - CCE 1.01b)
Interest Coverage Ratio = 7.75 (Ebit TTM 709.1m / Interest Expense TTM 91.5m)
EV/FCF = 20.48x (Enterprise Value 11.82b / FCF TTM 577.1m)
FCF Yield = 4.88% (FCF TTM 577.1m / Enterprise Value 11.82b)
FCF Margin = 19.30% (FCF TTM 577.1m / Revenue TTM 2.99b)
Net Margin = 15.75% (Net Income TTM 470.7m / Revenue TTM 2.99b)
Gross Margin = 38.22% ((Revenue TTM 2.99b - Cost of Revenue TTM 1.85b) / Revenue TTM)
Gross Margin QoQ = 35.43% (prev 40.00%)
Tobins Q-Ratio = 2.85 (Enterprise Value 11.82b / Total Assets 4.14b)
Interest Expense / Debt = 1.56% (Interest Expense 22.6m / Debt 1.45b)
Taxrate = 24.53% (30.6m / 124.6m)
NOPAT = 535.2m (EBIT 709.1m * (1 - 24.53%))
Current Ratio = 4.12 (Total Current Assets 1.71b / Total Current Liabilities 413.4m)
Debt / Equity = 0.72 (Debt 1.45b / totalStockholderEquity, last quarter 2.01b)
Debt / EBITDA = 0.49 (Net Debt 437.5m / EBITDA 895.1m)
Debt / FCF = 0.76 (Net Debt 437.5m / FCF TTM 577.1m)
Total Stockholder Equity = 1.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.15% (Net Income 470.7m / Total Assets 4.14b)
RoE = 25.82% (Net Income TTM 470.7m / Total Stockholder Equity 1.82b)
RoCE = 22.88% (EBIT 709.1m / Capital Employed (Equity 1.82b + L.T.Debt 1.28b))
RoIC = 17.33% (NOPAT 535.2m / Invested Capital 3.09b)
WACC = 10.54% (E(11.38b)/V(12.83b) * Re(11.73%) + D(1.45b)/V(12.83b) * Rd(1.56%) * (1-Tc(0.25)))
Discount Rate = 11.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.16%
[DCF] Terminal Value 69.65% ; FCFF base≈483.9m ; Y1≈491.3m ; Y5≈536.3m
[DCF] Fair Price = 75.04 (EV 6.28b - Net Debt 437.5m = Equity 5.85b / Shares 77.9m; r=10.54% [WACC]; 5y FCF grow 1.26% → 2.90% )
EPS Correlation: 21.82 | EPS CAGR: 25.62% | SUE: 0.76 | # QB: 0
Revenue Correlation: -4.82 | Revenue CAGR: 0.59% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.13 | Chg7d=-0.018 | Chg30d=+0.130 | Revisions Net=+4 | Analysts=6
EPS next Year (2027-03-31): EPS=6.86 | Chg7d=-0.025 | Chg30d=+0.415 | Revisions Net=+7 | Growth EPS=+12.0% | Growth Revenue=+13.0%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.6% (Discount Rate 11.7% - Earnings Yield 4.1%)
[Growth] Growth Spread = +5.2% (Analyst 12.8% - Implied 7.6%)